Advances in the development of new vaccines for tuberculosis and Brazil's role in the effort forward the end TB strategy

• Published in: Memórias do Instituto Oswaldo Cruz 2024, Vol.119, p.e240093
• Main Authors: Junqueira-Kipnis, Ana Paula, Leite, Luciana Cesar de Cerqueira, Croda, Júlio, Chimara, Erica, Carvalho, Anna Cristina C, Arcêncio, Ricardo Alexandre
• Format: Article
• Language: English
• Subjects: Brazil; COVID-19 - prevention & control; Humans; Pandemics - prevention & control; PARASITOLOGY; TROPICAL MEDICINE; Tuberculosis - epidemiology; Tuberculosis - prevention & control; Tuberculosis Vaccines; Vaccine Development
• ISSN: 0074-0276; 1678-8060; 1678-8060
• DOI: 10.1590/0074-02760240093

Tuberculosis (TB) continues to be the world's leading killer of infectious diseases. Despite global efforts to gradually reduce the number of annual deaths and the incidence of this disease, the coronavirus disease 19 (COVID-19) pandemic caused decreased in TB detection and affected the prompt treatment TB which led to a setback to the 2019 rates. However, the development and testing of new TB vaccines has not stopped and now presents the possibility of implanting in the next five years a new vaccine that is affordable and might be used in the various key vulnerable populations affected by TB. Then, this assay aimed to discuss the main vaccines developed against TB that shortly could be selected and used worldwide, and additionally, evidence the Brazilian potential candidates' vaccines in developing in Brazil that could be considered among those in level advanced to TB end.